- December 01, 2014
- SporeGen
-
Latest News
SporeGen® has been made a partner on the Horizon 2020 EMI-TB Grant focusing on developing innovative mucosal vaccines to TB, utilising the SporeGen® “SporeVax” technology. The grant is led by
Read More
- February 12, 2015
- SporeGen
-
SporeGen®is proud to be working with PATH and Dr. R. Aroian (University of Massachusetts) on a project that could ultimately lead to a significant impact on soil-transmitted helminth infections
Read More
- April 08, 2016
- SporeGen
-
Uncategorized
The Horizon 2020 EMI-TB Grant, focusing on developing innovative mucosal vaccines for TB, of which SporeGen® is a contributing partner, has launched a new website. The website will develop over the
Read More
- May 22, 2015
- SporeGen
-
Latest News
The SAPHIR project is an EU funded project whose full title is: Strengthening Animal Production and Health through the Immune Response. The general objective of SAPHIR is to generate
Read More
- May 30, 2015
- SporeGen
-
Latest News
The Economist magazine has recently published a special study on the potential beneficial breakthroughs that may soon be made in the study of the Human Microbiome, it’s the reason SporeGen®
Read More